AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
BENDAMUSTINE
6 registrations across 3 African markets— 3 active
Markets with BENDAMUSTINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| BAXIMO 25 mg | 🇿🇦South Africa | Adcock Ingram Limited | active | Feb 2031 |
| BENDAMUSTINE 25 mg ADCO | 🇿🇦South Africa | Adcock Ingram Limited | suspended | May 2025 |
| BENDAMUSTINE 100 mg ADCO | 🇿🇦South Africa | Adcock Ingram Limited | suspended | May 2025 |
| BEMUX Poudre pour solution injectable / 25 mg | 🇹🇳Tunisia | LABORATORIOS RICHMOND S.A.C.I.F. | expired | Sept 2021 |
| BEMUSTIN Lyophilized Injection | 🇹🇿Tanzania | PANACEA BIOTEC PHARMA LIMITED | active | — |
| Bendamustine Hydrochloride for injection Lyophilisade for the preparation of injection suspension with diluent | 🇹🇿Tanzania | Naprod Life sciences Pvt. Ltd | active | — |
BENDAMUSTINE in Africa — Regulatory Overview
BENDAMUSTINE is registered across 3 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tanzania, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 3 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.